These results suggest that expression of mutant K-ras and knocking down of p16 were sufficient for tumorigenic transformation of immortalized human pancreatic cells into pancreatic cancer cells and that mutation of K-ras and loss of p16 play important roles in the tumorigenic transformation. This evidence concerns the gene CDKN2A and pancreatic neoplasm.